
Investing in photonics, GSK and new opportunities in venture capital: Companies and Markets Show
From Investors' Chronicle by Investors' Chronicle
June 12, 2026 · 33 min
About this episode
The episode discusses Halma's results, GSK's acquisition of Nuvalent, and Molten Ventures' investment strategy.
This week’s show dives straight into safety and equipment maker Halma (HLMA) , which reported its full-year results on Thursday morning. It may be time to re-evaluate the company’s description as one of the FTSE 100’s least newsworthy businesses – it has been reaping the rewards of the AI boom. But with increased interest comes heightened expectations, and perhaps this is why its shares tumbled by 15 per cent on the day of the results. Mark Robinson digs into the details on whether this ‘quality stock’ is more volatile than it once was. We then turn to big pharma giant GSK (GSK) . The drugmaker made its largest deal in over a decade earlier this week with the acquisition of US cancer biotech Nuvalent. Julian Hofmann takes a look at the $11bn deal and what it means for the future of the pharmaceutical company. Finally we discuss venture capital trust Molten Ventures (GROW) , whose investments in the likes of fintech Revolut and microsatellite operator ICEYE have helped boost its returns. Mark is back to explore its portfolio and looks at whether the trust is morphing into something different. Timestamps 00:00 Introduction 01:22 Halma 14:47 GSK 23:06 Molten Ventures 32:25 Outro…
People in this episode
Hosts: Mark Robinson, Julian Hofmann
Topics covered
- photonic investing
- GSK acquisition
- venture capital
- Halma results
- AI impact
- pharmaceutical industry
- investment opportunities
Keywords
- Halma
- GSK
- Nuvalent
- Molten Ventures
- AI boom
- venture capital
- pharmaceuticals
- investing
Mentioned in this episode
Organizations: Halma, GSK, Nuvalent, Molten Ventures, Revolut, ICEYE
More episodes of Investors' Chronicle
- Investing in British Water, Nick Train & CMC: Companies and Markets Show · June 5, 2026 · 36 min
- ‘Bottlenecks are the best way to benefit from AI’: Ali Unwin of Polar Capital Technology · June 2, 2026 · 47 min
- SpaceX, Pets at Home & defence stocks: Companies and Markets Show · May 29, 2026 · 37 min
- Women and investing: How to start a business · May 26, 2026 · 32 min
- Cranswick, the perfect pension & palm oil: Companies and Markets Show · May 22, 2026 · 33 min
- Investing during volatility, property & Vodafone : Companies and Markets Show · May 15, 2026 · 33 min
Explore listener stats, chart rankings, contacts and more on the Investors' Chronicle podcast page.